M Notes on the design of bioequivelence study: emtricitabine/tenofovir/efavirenz PDF Guideline/guidance
M Notes on the design of bioequivelence study: ethambutol/isoniazid (16 January 2018) PDF Guideline/guidance
M Notes on the design of bioequivelence study: ethambutol/isoniazid/pyrazinamide/rifampicin PDF Guideline/guidance
M Notes on the design of bioequivelence study: ethambutol/isoniazid/rifampicin PDF Guideline/guidance
M Notes on the design of bioequivelence study: isoniazid/pyrazinamide/rifampicin PDF Guideline/guidance
M Notification of a change(s) to the key information of a product approved by a stringent regulatory authority (SRA) (4 December 2015) DOCX Application form
M Notification of an outcome of the national registration provided by the participating company to WHO-PQT, Annex 7 DOCX Template